PD10-01 DISEASE-FREE SURVIVAL WITH LONGER FOLLOW-UP FROM THE CHECKMATE 274 TRIAL OF ADJUVANT NIVOLUMAB IN PATIENTS AFTER SURGERY FOR HIGH-RISK MUSCLE-INVASIVE UROTHELIAL CARCINOMA
暂无分享,去创建一个
J. Witjes | M. Galsky | D. Bajorin | S. Park | S. Shariat | K. Unsal-Kaçmaz | Yoshihiko Tomita | S. Collette | T. Lebret | A. Bamias | F. Stenner | J. Gschwend | M. Agerbaek | M. Schenker | Joshua Zhang | G. Jha | F. Nasroulah | B. Valderrama